Echo IQ Ltd

Company profile

About Echo IQ Ltd

Echo IQ Ltd is a health AI company specializing in AI-powered solutions for detecting structural heart disease, with a primary focus on aortic stenosis (AS). The company's flagship product, EchoSolv AS, is an FDA-cleared artificial intelligence decision support algorithm that analyzes routine echocardiographic measurements to identify patients at increased probability of severe aortic stenosis and mortality risk. Unlike traditional approaches that rely on image analysis, Echo IQ's technology works exclusively with the numerical measurements already collected during standard echocardiograms, providing measurement-based decision support that delivers results in seconds at the point of clinical decision. The platform was developed using one of the world's largest echocardiographic measurement datasets, comprising over 200 million measurements, and is designed to complement clinician review without replacing clinical judgment. The company's mission is to leverage AI technology to enhance the identification of structural heart disease and support earlier, more accurate detection of life-threatening conditions. Their innovations are designed to optimize efficiency, consistency, throughput, and turnaround time while fitting seamlessly into existing clinical workflows with minimal disruption. Echo IQ's approach aims to reduce bias in detection, particularly addressing underdiagnosis in women, and to identify patients who might benefit from more definitive treatment or specialist care. Echo IQ's technology is supported by extensive clinical research published in leading cardiology journals, demonstrating the algorithm's effectiveness in identifying severe AS cases that may be missed by traditional guideline-based approaches. The company serves healthcare systems, cardiology practices, and echocardiography labs, with a focus on improving patient outcomes through AI-enhanced cardiac diagnostics.

Company description · Echo IQ Ltd official website